Safety of NXY-059 for the Treatment of Patients Who Have Suffered From a Stroke

Completed

Phase 2 Results

Summary of Purpose

This study will determine if NXY-059 is safe in patients with an acute stroke caused by bleeding in the central nervous system. The primary objective was to assess the safety and tolerability of NXY-059 compared to placebo.

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 3 January 2013.

1 Aug 2004 12 Jan 2004 1 Jan 2006 1 Jan 2006 1 Jan 2013 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Basics

Interventions

Conditions

Sponsors

Trial Design

  • Allocation: Randomized
  • Masking: Double-Blind
  • Purpose: Treatment
  • Endpoint: Safety/Efficacy Study
  • Intervention: Factorial Assignment

Contacts

Not available